Published in Clin Exp Immunol on June 01, 2000
Immunotherapy Using Autoclaved L. major Antigens and M. vaccae with Meglumine Antimoniate, for the Treatment of Experimental Canine Visceral Leishmaniasis. Iran J Parasitol (2011) 0.82
Maternal Deprivation of Lewis Rat Pups Increases the Severity of Experi-mental Periodontitis in Adulthood. Open Dent J (2015) 0.77
Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science (1992) 5.18
The bacterial etiology of destructive periodontal disease: current concepts. J Periodontol (1992) 4.76
Reactive oxygen species and antioxidants in inflammatory diseases. J Clin Periodontol (1997) 2.17
Role of matrix metalloproteinases in human periodontal diseases. J Periodontol (1993) 1.98
Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro. J Immunol (1996) 1.54
Models to evaluate the role of stress in periodontal disease. Ann Periodontol (1998) 1.46
Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae. Immunology (1998) 1.44
Induction of a type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae. Infect Immun (1997) 1.41
Protective effects of mercaptoethylguanidine, a selective inhibitor of inducible nitric oxide synthase, in ligature-induced periodontitis in the rat. Br J Pharmacol (1998) 1.18
Evidence of a direct relationship between neutrophil collagenase activity and periodontal tissue destruction in vivo: role of active enzyme in human periodontitis. J Periodontal Res (1995) 1.17
Genetic and heritable risk factors in periodontal disease. J Periodontol (1994) 1.13
Relevance of local Th2-type cytokine mRNA expression in immunocompetent infiltrates in inflamed gingival tissue to periodontal diseases. Clin Exp Immunol (1997) 1.10
Heat-shock proteins: immunity and autoimmunity. Curr Opin Immunol (1992) 1.10
Periodontal bone level and gingival proteinase activity in gnotobiotic rats immunized with Bacteroides gingivalis. Oral Microbiol Immunol (1991) 1.09
Exploratory case-control analysis of psychosocial factors and adult periodontitis. J Periodontol (1996) 1.07
Glucocorticoids inhibit bioactive IL-12p70 production by in vitro-generated human dendritic cells without affecting their T cell stimulatory potential. J Immunol (1998) 1.06
Release and activation of human neutrophil matrix metallo- and serine proteinases during phagocytosis of Fusobacterium nucleatum, Porphyromonas gingivalis and Treponema denticola. J Clin Periodontol (1997) 1.05
Modulation of colonization by black-pigmented Bacteroides species in squirrel monkeys by immunization with Bacteroides gingivalis. Infect Immun (1989) 1.05
Periodontal disease experience in adult long-duration insulin-dependent diabetics. J Clin Periodontol (1993) 1.04
Different regulation of adrenocorticotropin and cortisol secretion in young, mentally healthy elderly and patients with senile dementia of Alzheimer's type. J Clin Endocrinol Metab (1991) 1.03
Frequency distribution of individuals aged 20-70 years according to severity of periodontal disease. Community Dent Oral Epidemiol (1982) 1.02
Differential regulation of interleukin-10 (IL-10) and IL-12 by glucocorticoids in vitro. Blood (1998) 1.01
Psychosocial factors and adult onset rapidly progressive periodontitis. J Clin Periodontol (1996) 1.01
Serum cotinine levels, smoking, and periodontal attachment loss. J Dent Res (1996) 0.94
Activation of the hypothalamus-pituitary-adrenal axis by bacterial endotoxins: routes and intermediate signals. Psychoneuroendocrinology (1994) 0.93
Effects of immunization with B. macacae on induced periodontitis--preliminary findings. Immunol Invest (1989) 0.92
Smoking and periodontal disease severity. J Clin Periodontol (1995) 0.92
Nicotine stimulates the expression of cFos protein in the parvocellular paraventricular nucleus and brainstem catecholaminergic regions. Endocrinology (1993) 0.89
Superoxide formation and chemiluminescence of peripheral polymorphonuclear leukocytes in rapidly progressive periodontitis patients. J Clin Periodontol (1991) 0.84
Diabetes and periodontal diseases. J Periodontol (1996) 0.83
Cellular immunity and hypersensitivity as components of periodontal destruction. Oral Dis (1996) 0.81
Hypothalamo-pituitary-adrenal axis abnormalities in depression: a review and a model. Psychol Med (1989) 0.79
Assessment of hypothalamic-pituitary-adrenal function in the geriatric age group. J Gerontol (1969) 0.78
Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology (1986) 3.98
Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection. Lancet (2001) 3.71
A simple new method for using antigens separated by polyacrylamide gel electrophoresis to stimulate lymphocytes in vitro after converting bands cut from Western blots into antigen-bearing particles. J Immunol Methods (1987) 3.56
Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovis BCG. Infect Immun (1988) 3.35
Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages. Immunology (1986) 3.33
Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumour necrosis factor from human and murine macrophages. Clin Exp Immunol (1989) 3.09
I-A restricted activation by T cell lines of anti-tuberculosis activity in murine macrophages. Clin Exp Immunol (1985) 2.73
Mycobacterium tuberculosis DNA in tissue affected by sarcoidosis. BMJ (1993) 2.58
Tumour necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome. Lancet (1989) 2.43
A simple method for the solubilisation of reduced NBT, and its use as a colorimetric assay for activation of human macrophages by gamma-interferon. J Immunol Methods (1985) 2.38
The secreted antigens of Mycobacterium tuberculosis and their relationship to those recognized by the available antibodies. J Gen Microbiol (1988) 2.38
How environmental mycobacteria may predetermine the protective efficacy of BCG. Tubercle (1981) 2.34
Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. J Infect Dis (2000) 2.08
The role of TNF-alpha in T-cell-mediated inflammation depends on the Th1/Th2 cytokine balance. Immunology (1994) 2.08
Cellular immune response to common mycobacterial antigens in subjects seropositive for Trypanosoma cruzi. Lancet (1994) 2.06
Characterization of T cell antigens associated with the cell wall protein-peptidoglycan complex of Mycobacterium tuberculosis. J Immunol (1989) 2.01
Smoking and tuberculosis: the epidemiological association and immunopathogenesis. Trans R Soc Trop Med Hyg (2005) 1.88
Raised serum IgG and IgA antibodies to mycobacterial antigens in rheumatoid arthritis. Ann Rheum Dis (1989) 1.85
Preliminary taxonomic studies on the leprosy bacillus. Br J Exp Pathol (1975) 1.83
Role of activated macrophages in the immunopathology of tuberculosis. Br Med Bull (1988) 1.75
Genetic and immunological analysis of Mycobacterium tuberculosis fibronectin-binding proteins. Infect Immun (1991) 1.69
Specific detection of Mycobacterium paratuberculosis DNA associated with granulomatous tissue in Crohn's disease. Gut (1994) 1.57
Attachment of mycobacteria to fibronectin-coated surfaces. J Gen Microbiol (1988) 1.56
An inhibitor of the toxicity of tumour necrosis factor in the serum of patients with sarcoidosis, tuberculosis and Crohn's disease. Clin Exp Immunol (1990) 1.53
Antibody levels to mycobacteria in relation to HLA type: evidence for non-HLA-linked high levels of antibody to the 65 kD heat shock protein of M. bovis in rheumatoid arthritis. Clin Exp Immunol (1988) 1.53
Elevated IgG antibody levels to the mycobacterial 65-kDa heat shock protein are characteristic of patients with rheumatoid arthritis. Scand J Immunol (1989) 1.49
Autoimmune reactions to heat-shock proteins in pristane-induced arthritis. Eur J Immunol (1990) 1.48
Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae. Immunology (1998) 1.44
Human and murine macrophages produce TNF in response to soluble antigens of Plasmodium falciparum. Parasite Immunol (1990) 1.40
The immunological consequences of antigen overload in experimental mycobacterial infections of mice. Clin Exp Immunol (1975) 1.35
Three forms of delayed skin-test response evoked by mycobacteria. Nature (1978) 1.32
Effect of mycobacteria on sensitivity to the cytotoxic effects of tumor necrosis factor. Infect Immun (1991) 1.31
Preliminary evidence for the trapping of antigen-specific lymphocytes in the lymphoid tissue of 'anergic' tuberculosis patients. Clin Exp Immunol (1976) 1.30
Responsiveness to live M. tuberculosis, and common antigens, of sonicate-stimulated T cell lines from normal donors. Clin Exp Immunol (1986) 1.28
The effect of lymph-node cells from specifically sensitised mice, on the growth of the BP8 ascites tumor "in vivo" and "in vitro". Br J Exp Pathol (1968) 1.28
The effect of two distinct forms of cell-mediated response to mycobacteria on the protective efficacy of BCG. Tubercle (1981) 1.22
Use of the ELISA to screen for anti-thymocyte and anti-beta 2-microglobulin antibodies in leprosy and SLE. Immunology (1980) 1.22
The potentiating, mitogenic and inhibitory effects on lymphocytes in vitro, of macrophages in the lymph nodes of mice 'overloaded' with mycobacterial products. Clin Exp Immunol (1975) 1.21
Taxonomic studies on the leprosy bacillus. Int J Lepr Other Mycobact Dis (1976) 1.19
HLA-DR3 associated genetic control of response to multiple skin tests with new tuberculins. Clin Exp Immunol (1983) 1.19
An inexpensive, portable, battery-operated photometer for the reading of ELISA tests in microtitration plates. J Immunol Methods (1981) 1.19
Analysis of glycosylation changes in IgG using lectins. J Immunol Methods (1990) 1.17
Does antibody to mycobacterial antigens, including lipoarabinomannan, limit dissemination in childhood tuberculosis? Trans R Soc Trop Med Hyg (1993) 1.17
Interpretation of Mycobacterium tuberculosis antigen-specific IFN-gamma release assays (T-SPOT.TB) and factors that may modulate test results. J Infect (2007) 1.17
The effect of Mycobacterium tuberculosis on the susceptibility of human cells to the stimulatory and toxic effects of tumour necrosis factor. Immunology (1992) 1.16
Maintained pregnancy levels of oestrogen afford complete protection from post-partum exacerbation of collagen-induced arthritis. Clin Exp Immunol (1991) 1.15
Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein. Gut (1990) 1.14
A preliminary investigation of the responsiveness or otherwise of patients and staff of a leprosy hospital to groups of shared or species antigens of mycobacteria. Lepr Rev (1981) 1.13
HLA-DR-associated isotype-specific regulation of antibody levels to mycobacteria in rheumatoid arthritis. Clin Exp Immunol (1988) 1.12
Inhibition of virulent Mycobacterium tuberculosis by murine peritoneal macrophages and human alveolar lavage cells: the effects of lymphokines and recombinant gamma interferon. Tubercle (1986) 1.12
Interactions between hormone-mediated and vaccine-mediated immunotherapy for pulmonary tuberculosis in BALB/c mice. Immunology (2000) 1.11
Characterization of the secreted antigens of Mycobacterium bovis BCG: comparison of the 46-kilodalton dimeric protein with proteins MPB64 and MPB70. Infect Immun (1987) 1.10
Pulmonary bovine-type tuberculosis in rabbits: bacillary virulence, inhaled dose effects, tuberculin sensitivity, and Mycobacterium vaccae immunotherapy. Clin Diagn Lab Immunol (1998) 1.07
Early agalactosylation of IgG is associated with a more progressive disease course in patients with rheumatoid arthritis: results of a follow-up study. Br J Rheumatol (1994) 1.07
FOXP3 gene expression in a tuberculosis case contact study. Clin Exp Immunol (2007) 1.06
The immunological consequences of challenge with bovine tubercle bacilli in badgers (Meles meles). Epidemiol Infect (1987) 1.05
TNF alpha-mediated tissue damage in mouse footpads primed with mycobacterial preparations. Res Immunol (1993) 1.04
Relationship between interleukin 6, agalactosyl IgG and pristane-induced arthritis. Autoimmunity (1992) 1.03
A transient rise in agalactosyl IgG correlating with free interleukin 2 receptors, during episodes of erythema nodosum leprosum. Clin Exp Immunol (1989) 1.03
TH1/TH2 switching and loss of CD4+ T cells in chronic infections: an immunoendocrinological hypothesis not exclusive to HIV. Immunol Today (1993) 1.03
The effect of lymphokines on the ability of macrophages to protect mycobacteria from a bactericidal antibiotic. Tubercle (1985) 1.00
The immunogenicity of killed mycobacteria. Lepr Rev (1980) 1.00
Adrenal changes in murine pulmonary tuberculosis; a clue to pathogenesis? FEMS Immunol Med Microbiol (1995) 0.99
Agalactosyl IgG in pristane-induced arthritis. Pregnancy affects the incidence and severity of arthritis and the glycosylation status of IgG. Clin Exp Immunol (1992) 0.99
Inhibition of the proliferative response of peripheral blood lymphocytes to mycobacterial or fungal antigens by co-stimulation with antigens from various mycobacterial species. Immunology (1981) 0.99
The dissociation of adjuvant properties of mycobacterial components from mitogenicity, and from the ability to induce the release of mediators from macrophages. Immunology (1976) 0.98
Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity. Hum Antibodies Hybridomas (1994) 0.98
Tuberculosis and cancer: parallels in host responses and therapeutic approaches? Lancet (1995) 0.97
Influence of 1,25-(OH)2 vitamin D3 and gamma interferon on the phenotype of human peripheral blood monocyte-derived macrophages. Infect Immun (1987) 0.96
Mycobacterium vaccae in immunoprophylaxis and immunotherapy of leprosy and tuberculosis. Vaccine (1990) 0.96
A model for the investigation of factors influencing haemorrhagic necrosis mediated by tumour necrosis factor in tissue sites primed with mycobacterial antigen preparations. Clin Exp Immunol (1992) 0.95
The relevance to protection of three forms of delayed skin-test response evoked by m. leprae and other mycobacteria in mice. Correlation with the classical work in the guinea-pig. Parasite Immunol (1979) 0.94
Old plague, new plague, and a treatment for both? AIDS (1993) 0.93
Interleukin-4 and its alternatively spliced variant (IL-4delta2) in patients with atopic asthma. Am J Respir Crit Care Med (2001) 0.93
The biological activity of human monoclonal IgG anti-D is reduced by beta-galactosidase treatment. Hum Antibodies Hybridomas (1995) 0.93
The effects of androstenediol and dehydroepiandrosterone on the course and cytokine profile of tuberculosis in BALB/c mice. Immunology (1998) 0.92
High levels of mRNA encoding IL-4 in unstimulated peripheral blood mononuclear cells from tuberculosis patients revealed by quantitative nested reverse transcriptase-polymerase chain reaction; correlations with serum IgE levels. Scand J Infect Dis (2001) 0.92
The development of monoclonal antibodies to the human mitochondrial 60-kd heat-shock protein, and their use in studying the expression of the protein in rheumatoid arthritis. Arthritis Rheum (1992) 0.91
Rheumatoid arthritis: how well do the theories fit the evidence? Clin Exp Immunol (1993) 0.91
The immunology of leprosy. Tubercle (1983) 0.91
Effect of the method of preparation of bacille Calmette-Guérin (BCG) vaccine on the properties of four daughter strains. J Appl Bacteriol (1987) 0.90
Immunotherapy with Mycobacterium vaccae as an addition to chemotherapy for the treatment of pulmonary tuberculosis under difficult conditions in Africa. Respir Med (1995) 0.90
Immunotherapy with Mycobacterium vaccae as an adjunct to chemotherapy in the treatment of pulmonary tuberculosis. Tubercle (1990) 0.90
A sensitive, non-radioactive quantitative method for measuring IL-4 and IL-4delta2 mRNA in unstimulated cells from multiple clinical samples, using nested RT-PCR. J Immunol Methods (1999) 0.89
T-cell-dependent polyclonal activation by soluble mycobacterial extracts of B cells in peripheral blood mononuclear cell populations from leprosy patients and normal donors. Immunology (1982) 0.89
Prevalence and specificity of the enhancing effect of three types of interleukin 2 on T cell responsiveness in 97 lepromatous leprosy patients of mixed ethnic origin. Clin Exp Immunol (1986) 0.89
Is the macrophage the site of the immunosuppressive action of rifampicin? Tubercle (1973) 0.89
IgG glycosylation in autoimmune-prone strains of mice. Clin Exp Immunol (1994) 0.89
Prostaglandin-dependent regulation of the in vitro proliferative response to mycobacterial antigens of peripheral blood lymphocytes from normal donors and from patients with tuberculosis or leprosy. Clin Exp Immunol (1981) 0.88
Il-4 influences apoptosis of mycobacterium-reactive lymphocytes in the presence of TNF-alpha. J Immunol (2001) 0.88
The immune response in two populations of wild badgers naturally infected with bovine tubercle bacilli. Tubercle (1987) 0.88
The demonstration of two types of suppressor mechanism in leprosy patients and their contacts by quadruple skin-testing with mycobacterial reagent mixtures. Lepr Rev (1983) 0.88
Suppressor determinants of mycobacteria and their potential relevance to leprosy. Lepr Rev (1986) 0.87
HIV infection alters the production of both type 1 and 2 cytokines but does not induce a polarized type 1 or 2 state. AIDS (1997) 0.86
Differing role of dendritic cells and macrophages in the induction of delayed-type hypersensitivity responses to PPD. Immunology (1986) 0.86
Oral treatment with complement factor C5a receptor (CD88) antagonists inhibits experimental periodontitis in rats. J Periodontal Res (2011) 0.85
Preliminary immunological studies in search of correlates of protective immunity carried out on some Iranian leprosy patients and their families. Lepr Rev (1980) 0.84